A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyBarbara K. Burton, Anthony Quinn, Manisha Balwani et al.|New England Journal of Medicine|2015Cited by 244
Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedureMinke H. de Ru, Frits A. Wijburg, Jaap Jan Boelens et al.|Orphanet Journal of Rare Diseases|2011Cited by 233
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled studyChristian J. Hendriksz, Wolfgang Dummer, Barbara K. Burton et al.|Journal of Inherited Metabolic Disease|2014Cited by 211
Disease and patient characteristics in NP-C patients: findings from an international disease registryMarc C. Patterson, Mercè Pineda, Eugen Mengel et al.|Orphanet Journal of Rare Diseases|2013Cited by 197
The definition of neuronopathic Gaucher diseaseRaphael Schiffmann, Ari Zimran, Tama Dinur et al.|Journal of Inherited Metabolic Disease|2020Cited by 102